United States - English - NLM (National Library of Medicine)

valeant pharmaceuticals north america llc - desirudin (unii: u0jz726775) (desirudin - unii:u0jz726775) - desirudin 30 mg in 1 ml

European Union - English - EMA (European Medicines Agency)

canyon pharmaceuticals ltd. - desirudin - venous thrombosis - antithrombotic agents - prevention of deep venous thrombosis in patients undergoing elective hip or knee replacement surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

emerge health pty ltd - desirudin -

United States - English - NLM (National Library of Medicine)

uriel pharmacy inc - aesculus glabra nut (unii: ihy79hc33c) (aesculus glabra nut - unii:ihy79hc33c), hamamelis virginiana root bark/stem bark (unii: t7s323pkjs) (hamamelis virginiana root bark/stem bark - unii:t7s323pkjs), paeonia officinalis root (unii: 8r564u2e1p) (paeonia officinalis root - unii:8r564u2e1p), pulsatilla vulgaris (unii: i76kb35jev) (pulsatilla vulgaris - unii:i76kb35jev), desirudin (unii: u0jz726775) (desirudin - unii:u0jz726775), mercury (unii: fxs1by2pgl) (mercury - unii:fxs1by2pgl) - aesculus glabra nut 3 [hp_x] - directions: for oral use only. use: temporary relief of varicose veins.

New Zealand - English - Medsafe (Medicines Safety Authority)

sanofi-aventis new zealand limited - desirudin 15mg - injection with diluent - 15 mg - active: desirudin 15mg excipient: magnesium hydroxide sodium hydroxide mannitol water for injection

Australia - English - Department of Health (Therapeutic Goods Administration)

boehringer ingelheim pty ltd - dabigatran etexilate mesilate -

New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 126.83mg equivalent to dabigatran etexilate 110 mg;  ;   - capsule - 110 mg - active: dabigatran etexilate mesylate 126.83mg equivalent to dabigatran etexilate 110 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 1 - (tt70-14-2-2) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg;  ;   - capsule - 150 mg - active: dabigatran etexilate mesylate 172.95mg equivalent to dabigatran etexilate 150 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 0 (tt70-14-2-4) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

New Zealand - English - Medsafe (Medicines Safety Authority)

boehringer ingelheim (nz) limited - dabigatran etexilate mesylate 86.48mg equivalent to dabigatran etexilate 75 mg;  ;   - capsule - 75 mg - active: dabigatran etexilate mesylate 86.48mg equivalent to dabigatran etexilate 75 mg     excipient: acacia dimeticone hyprolose hypromellose hpmc capsule size 2 - (tt70-14-2-3) purified talc tartaric acid tekprint black sw-9008 - prevention of venous thromboembolic events in patients who have undergone major orthopaedic surgery.

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate - capsule - 110 mg - dabigatran etexilate mesilate 126.83 mg eqv dabigatran etexilate 110 mg